 |
Dépôt minimal $50 Promotion exclusive |
Notre score |
Commission 0% |
Are you looking to buy Pacira BioSciences stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:PCRX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Pacira BioSciences stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Volume moyen
595,879 shs
CAP DE MARCHÉ
$3.27 billion
Bourse
NASDAQ
Achetez cette action !
|
NOM
|
TICKER
|
INDUSTRIE
|
SECTEUR
|
VOLUME
|
ACHETEZ CETTE ACTION MAINTENANT
|
|---|---|---|---|---|---|
|
NASDAQ:PCRX
|
Préparations pharmaceutiques
|
Médical
|
6,779 shs
|
Below is a quick guide on how to buy NASDAQ:PCRX stocks safe, fast and around the world in less than five minutes.
Étape 1 : Ouvrir un compte chez eToro – eToro is the best broker to buy Pacira BioSciences shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Étape 2 : Téléchargez votre ID - Conformément à la réglementation KYC, eToro vous demandera de télécharger une copie de votre passeport ou de votre permis de conduire.
Étape 3 : Dépôt des fonds - Déposez de l'argent sur votre compte eToro nouvellement créé. Vous pouvez choisir entre un virement bancaire, un portefeuille électronique, une carte de débit/crédit ou Paypal.
Étape 4 : Buy Pacira BioSciences – Search for “”NASDAQ:PCRX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Pacira BioSciences stocks with 0% commission!.
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
11 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Pacira BioSciences in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Pacira BioSciences stock.
Wall Street analysts have given Pacira BioSciences a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Pacira BioSciences wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
2 |  | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
3 |  | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:PCRX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Pacira BioSciences stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Pacira BioSciences stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Comme eToro est une plateforme réglementée, vous devrez remplir le processus KYC, c'est une pratique standard et cela ne prend que quelques minutes. Vous devrez fournir une pièce d'identité avec photo (passeport, permis de conduire) et un justificatif de domicile (facture d'électricité, relevé bancaire).
Une fois que vous vous êtes inscrit et que vous avez vérifié votre compte, vous devrez déposer des fonds. eToro accepte les cartes de crédit/débit, les virements bancaires et également les portefeuilles électroniques. Donc, quelle que soit votre préférence, il y aura quelque chose pour vous.
Now that you’ve funded your eToro account, just type “NASDAQ:PCRX stocks" dans la barre de recherche en haut de l'écran et appuyez sur "commerce".
All that’s left is to buy some NASDAQ:PCRX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:PCRX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Pacira BioSciences stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Pacira BioSciences is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Pacira BioSciences.
Pacira BioSciences, Inc. (NASDAQ:PCRX) issued its earnings results on Thursday, October, 29th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.03. The firm had revenue of $117.50 million for the quarter, compared to the consensus estimate of $115.95 million. Pacira BioSciences had a trailing twelve-month return on equity of 10.71% and a net margin of 29.95%. The business’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $0.48 earnings per share.
View Pacira BioSciences’ earnings history.
Pacira BioSciences’ stock was trading at $35.19 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PCRX shares have increased by 115.0% and is now trading at $75.65.
Pacira BioSciences issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, January, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $429.6-429.6 million, compared to the consensus revenue estimate of $427.7 million.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:PCRX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Plus de 95% des fonds des clients sont conservés hors ligne, en chambre froide, ce qui est crucial pour tout courtier qui gère vos actifs. Quel que soit le degré de sécurité d'une plateforme, nous vous recommandons d'utiliser le 2FA pour ajouter une couche supplémentaire de sécurité à votre compte.
eToro offre aux utilisateurs une série de fonctionnalités pour commencer à investir le plus rapidement possible. Ils ont une fonction relativement unique appelée copy trading, qui vous permet de gagner un revenu passif en reproduisant des traders expérimentés, cela vous permet de commencer à gagner du profit rapidement, et vous donne une meilleure compréhension des stratégies utilisées par les professionnels. De plus, eToro permet aux utilisateurs d'investir dans des portefeuilles gérés, un portefeuille géré étant une variété d'actifs similaires regroupés, vous permettant de diversifier votre compte, réduisant ainsi tout risque potentiel. Pour ceux qui ont déjà une expérience du trading, vous pouvez investir dans des marchés autres que les actions, car eToro permet aux utilisateurs de négocier des ETF, des matières premières, des crypto et des indices. Si vous investissez déjà en dehors de l'espace boursier, cela peut être très utile, car cela vous permet de gérer tous vos investissements en un seul endroit.
11 analysts have issued 12-month target prices for Pacira BioSciences’ stock. Their forecasts range from $48.00 to $90.00. On average, they expect Pacira BioSciences’ stock price to reach $73.00 in the next year. This suggests that the stock has a possible downside of 3.5%.
View analysts’ price targets for Pacira BioSciences or view top-rated stocks among Wall Street analysts.
Pacira BioSciences’ management team includes the following people:
Mr. David M. Stack, Chairman & CEO (Age 71, Pay $1.47M)
Mr. Charles A. Reinhart III, CPA, M.B.A., Chief Financial Officer (Age 60, Pay $637.22k)
Ms. Kristen Williams, Chief Admin. Officer & Sec. (Age 47, Pay $727.97k)
Dr. Roy Winston, Chief Clinical Officer (Age 60, Pay $647.06k)
Mr. Max Reinhardt, Pres of ROW (Age 50, Pay $619.19k)
Ms. Lauren Bullaro Riker, Principal Accounting Officer & VP of Fin. (Age 42)
Mr. Charles Laranjeira, Chief Technical Officer (Age 55)
Susan Mesco, Head of Investor Relations
Mr. Richard Kahr, VP of HR
Mr. Robert J. Weiland, Sr. VP of Alliance Management (Age 61)
Les CFD sont des instruments complexes et comportent un risque élevé de perdre rapidement de l'argent en raison de l'effet de levier. 68% des comptes d'investisseurs particuliers perdent de l'argent lorsqu'ils négocient des CFD avec ce fournisseur. Vous devez vous demander si vous comprenez le fonctionnement des CFD et si vous pouvez vous permettre de prendre le risque élevé de perdre votre argent.
54 employees have rated Pacira BioSciences CEO Dave Stack on Glassdoor.com. Dave Stack has an approval rating of 45% among Pacira BioSciences’ employees. This puts Dave Stack in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to Pacira BioSciences include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of PCRX’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Pacira BioSciences investors own include Gilead Sciences (GILD), NVIDIA (NVDA), Micron Technology (MU), ACADIA Pharmaceuticals (ACAD), Skyworks Solutions (SWKS), AbbVie (ABBV), Pfizer (PFE), QUALCOMM (QCOM), Exelixis (EXEL) and Tesla (TSLA).
Pacira BioSciences trades on the NASDAQ under the ticker symbol “PCRX.”
1 | | Dépôt minimal $50 Promotion exclusive | Notre score 10 ★★★★★ | Commission 0% |
Pacira BioSciences’ stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.34%), Frontier Capital Management Co. LLC (2.38%), Peregrine Capital Management LLC (0.51%), Tributary Capital Management LLC (0.35%), British Airways Pensions Investment Management Ltd (0.33%) and MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income (0.33%). Company insiders that own Pacira BioSciences stock include Andreas Wicki, Charles A Reinhart III, Charles Anthony Laranjeira, David M Stack, Dennis Mcloughlin, John P Phd Longenecker, Kristen Marie Williams, Laura Brege, Lauren Bullaro Riker, Mark A Kronenfeld, Max Reinhardt, Paul J Hastings, Richard Scranton and Roy Winston.
View institutional ownership trends for Pacira BioSciences.
PCRX stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Peregrine Capital Management LLC, British Airways Pensions Investment Management Ltd, State of Wisconsin Investment Board, First Trust Advisors LP, State of Alaska Department of Revenue, Texas Permanent School Fund, and THB Asset Management. Company insiders that have sold Pacira BioSciences company stock in the last year include Andreas Wicki, Charles A Reinhart III, Charles Anthony Laranjeira, David M Stack, Kristen Marie Williams, Laura Brege, Lauren Bullaro Riker, Max Reinhardt, Paul J Hastings, and Roy Winston.
View insider buying and selling activity for Pacira BioSciences or view top insider-selling stocks.
PCRX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Zweig DiMenna Associates LLC, Assenagon Asset Management S.A., MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income, Tributary Capital Management LLC, Crossmark Global Holdings Inc., HGK Asset Management Inc., and Nisa Investment Advisors LLC. Company insiders that have bought Pacira BioSciences stock in the last two years include Mark A Kronenfeld, and Roy Winston.
View insider buying and selling activity for Pacira BioSciences or or view top insider-buying stocks.
Shares of PCRX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revue de Interactive Brokers, Revue d'eToro, Revue DEGiro, Revue d'AvaTrade, Examen d'IG Markets, Revue des marchés IC, Revue de CMC Markets, Revue Admiral Markets et bien d'autres encore. Lisez l'une des critiques pour tout savoir sur le courtier et commencez à acheter des actions dès maintenant.
One share of PCRX stock can currently be purchased for approximately $75.65.
Pacira BioSciences has a market capitalization of $3.29 billion and generates $421.03 million in revenue each year. The company earns $-11,020,000.00 in net income (profit) each year or $0.86 on an earnings per share basis.
A Reportlab.org, nous voulons nous assurer que vous disposez de toutes les informations les plus pertinentes sur acheter des actions. Nous vous apportons les meilleurs guides sur le marché boursier avec des critiques personnelles, des informations de fond, des critiques de plateformes, des modes d'emploi et plus encore. Vous voulez obtenir d'autres informations ? Alors consultez le Actions OTC, Actions du NASDAQ, Actions du NYSE, Actions LON, Stocks FRA, Stocks ETR, Stocks EPA, Actions de la TSX ou Actions Amex. Vous cherchez des informations plus détaillées comme Stocks de 5g, actions de biotechnologie, stocks d'or et d'autres informations de notre reportlab.
How can you buy Pacira BioSciences stock on the internet?
You can easily buy Pacira BioSciences stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Une autre option consiste à utiliser un courtier réglementé comme Marchés IC ou Courtiers interactifs. You can an account with these brokers and start buying or trading NASDAQ:PCRX stocks in a safe and complete environment to trade in.
Where to buy Pacira BioSciences stock?
You will first want to find a licensed broker that supports NASDAQ:PCRX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:PCRX stocks in a safe and complete environment.
Is NASDAQ:PCRX stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:PCRX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Pacira BioSciences stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:PCRX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Pacira BioSciences stock.
How do you trade Pacira BioSciences stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Pacira BioSciences stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:PCRX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Pacira BioSciences stock?
To sell your NASDAQ:PCRX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Pacira BioSciences stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:PCRX stock.
Stephen connaît bien les produits financiers et a notamment une grande passion pour les marchés boursiers et leurs participants. Nous espérons que les informations fournies vous aideront. Quelque chose n'est pas tout à fait clair ? Veuillez laisser vos questions ou commentaires au bas de la page.
| Notre score ★★★★★ | |
| Notre score ★★★★★ | |
| Notre score ★★★★★ |
Bulletin d'information
Nouvelles récentes
| |
Notre score |
Commission 0% |
Données en temps réel sur les actions et les crypto-monnaies
Notifications, conseils et actualités
Guides des meilleures actions et crypto
Critiques sur les courtiers et les bourses en ligne
Reportlab Finance est un site purement informatif et n'implique en aucun cas des conseils en matière d'investissement. Tous les investissements comportent des risques et vous pouvez perdre tous vos investissements. N'investissez pas l'argent que vous ne pouvez pas vous permettre de perdre.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Royaume-Uni
Copyright © 2022 Reportlab.Finance | Tous droits réservés.
